Imaging of brain tumors: MR spectroscopy and metabolic imaging.
The utility of magnetic resonance spectroscopy (MRS) in diagnosis and evaluation of treatment response to human brain tumors has been widely documented. The role of MRS in tumor classification, tumors versus nonneoplastic lesions, prediction of survival, treatment planning, monitoring of therapy, and post-therapy evaluation is discussed. This article delineates the need for standardization and further study in order for MRS to become widely used as a routine clinical tool.
Horská
Alena
A
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Barker
Peter B
PB
D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D001927:Brain Diseases / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000378:metabolism* / Q000628:therapy; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D009361:Neoplasm Invasiveness; D016019:Survival Analysis